← Back to Search

Behavioural Intervention

EGS Delirium Recovery Program for Post-Surgery Delirium

N/A

Recruiting

Led By Ben Zarzaur, MD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Discharged to home or sub-acute rehabilitation

Adult age 65 years and older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months, 12 months, and 18 months

Awards & highlights

Study Summary

This trial will study whether the Emergency General Surgery Delirium Recovery Model can help people recover better from delirium. It will last 18 months.

Who is the study for?

This trial is for adults aged 65 or older who have had emergency abdominal surgery, experienced delirium before discharge, and can consent to participate. They must speak English and have access to a phone or internet device. Excluded are those with certain neurodegenerative diseases, severe brain injuries, cancer with short life expectancy, recent substance abuse issues, or undergoing chemotherapy/radiation.Check my eligibility

What is being tested?

The study tests the EGS Delirium Recovery Model's effectiveness in aiding cognitive, physical and psychological recovery after surgery-related delirium in older patients. Participants will be involved for 18 months and engage with recovery programs alongside regular questionnaires.See study design

What are the potential side effects?

Since this trial involves a recovery program rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience discomfort or fatigue from engaging in the activities of the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was sent home or to a rehab center after hospital discharge.

Select...

I am 65 years old or older.

Select...

I had emergency abdominal surgery, such as for a bowel issue or ulcer.

Select...

I experienced confusion or delirium before leaving the hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months, 12 months, and 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months, 12 months, and 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months, 12 months, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in overall cognitive recovery

Secondary outcome measures

Change in overall physical recovery

General Anxiety Disorder-7 (GAD-7) .

Patient Health Questionnaire-9 (PHQ-9)

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Usual CareExperimental Treatment1 Intervention

Participants will receive the usual rehabilitation and post-operative care.

Group II: EGS Delirium ModelExperimental Treatment2 Interventions

The delivery of the model will occur in five phases that correspond to the known stages of recovery after surgery. During the acute stage (0 - 1 month after surgery), participants will undergo the initial case review and two initial virtual visits, and the development of the recovery care plan. During the recovery (2 - 6 months after surgery) and maintenance (7-12 months after surgery) stages, the participants will undergo the interaction phase of the EGS Delirium Recovery Model.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

SwedishAmerican HospitalUNKNOWN

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,357 Total Patients Enrolled

35 Trials studying Delirium

38,097 Patients Enrolled for Delirium

University of Wisconsin, MadisonLead Sponsor

1,189 Previous Clinical Trials

3,169,018 Total Patients Enrolled

5 Trials studying Delirium

8,566 Patients Enrolled for Delirium

Media Library

EGS Delirium Recovery Program (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05373017 — N/A

Delirium Research Study Groups: EGS Delirium Model, Usual Care

Delirium Clinical Trial 2023: EGS Delirium Recovery Program Highlights & Side Effects. Trial Name: NCT05373017 — N/A

EGS Delirium Recovery Program (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05373017 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this experiment open at the moment?

"Clinicaltrials.gov has reported that this medication trial is no longer open for enrollment, with the initial posting date on January 1st 2023 and final update occurring October 31st 2022. Though recruitment for this particular study has been closed, there are currently 341 other trials actively seeking patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors

2023. "Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05373017.

All > Psychological